tradingkey.logo

Neuronetics Inc <STIM.OQ> expected to post a loss of 25 cents a share - Earnings Preview

ReutersJan 24, 2025 1:46 PM
  • Neuronetics Inc STIM.OQ STIM.O is expected to show a fall in quarterly revenue when it reports results on January 27 (estimated) for the period ending December 31 2024

  • The Malvern Pennsylvania-based company is expected to report a 6.5% decrease in revenue to $18.984 million from $20.31 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $19.00 million and $20.00 million.

  • ​LSEG's mean analyst estimate for Neuronetics Inc is for a loss of 25 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Neuronetics Inc is $3.00​, above​ its last closing price of $2.39. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.23

-0.23

-0.44

Missed

-91.3

Jun. 30 2024

-0.27

-0.27

-0.33

Missed

-22.2

Mar. 31 2024

-0.32

-0.31

-0.27

Beat

12.9​

Dec. 31 2023

-0.26

-0.26

-0.19

Beat

27.3

​​Sep. 30 2023

-0.31

-0.31

-0.33

Missed

-6.7

Jun. 30 2023

-0.35

-0.35

-0.17

Beat

51.2​

Mar. 31 2023

-0.39

-0.39

-0.38

Beat

2.1

Dec. 31 2022

-0.35

-0.38

-0.30

Beat

21.3

This summary was machine generated January 24 at 13:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI